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SummAry
recurrence of differentiated thyroid cancer can often require further surgical options. reoperations may carry significant risk of surgical 
complications; additionally, as the anatomy is subverted, there is the possibility of leaving residual neoplasm. in order to avoid such prob-
lems during reoperation for differentiated thyroid cancer recurrence, we have introduced the technique of preoperative ultrasound-guided 
tattooing localization of the lymphatic structure to be removed with a 4% solution of active charcoal. using ultrasound guidance, the le-
sion is identified and 0.5-2 ml of colloidal charcoal is injected near the lesion. The extraction of the needle is accompanied by injection 
at constant pressure of other charcoal as to leave a trace of colouring along the path of the needle up to the skin. The preoperative injec-
tion was well tolerated in all cases. in the last 5 years, we have used this technique in 13 patients with suspected recurrence in the central 
compartment (all from papillary carcinomas). Postoperative ultrasound and histological examination confirmed the removal of the lesion 
in all patients; in one case, the lesion was a parathyroid cyst. Complications were observed in two of 13 (15.4%) cases (one transitory hy-
poparathyroidism, and one transitory vocal cord paresis). Considering our experience, charcoal tattoo localization can be considered a safe, 
low-cost technique that is extremely useful for facilitating surgical procedures, and reduces the risk of iatrogenic damage.  
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riASSunTo
Le recidive linfonodali dei carcinomi tiroidei differenziati spesso richiedono ulteriori opzioni chirurgiche. I reinterventi sono caratterizzati 
da un numero più elevato di complicanze; inoltre, essendo i rapporti anatomici alterati esiste la possibilità di lasciare sul campo operatorio 
dei residui neoplastici. Al fine di ovviare, almeno parzialmente, a queste problematiche legate ai reinterventi per recidive linfonodali di 
carcinomi tiroidei differenziati, abbiamo introdotto nella nostra struttura ospedaliera la tecnica della marcatura pre-operatoria, ECO-
guidata, con una soluzione di carbone vegetale al 4%, della lesione da rimuovere. Sotto guida ecografia, nello spazio adiacente la struttura 
linfatica, viene iniettata una quantità di circa 0,5-2 ml di soluzione di carbone; l’estrazione dell’ago è accompagnata da una iniezione a 
pressione costante di altra soluzione in modo da lasciare una traccia di colorante lungo il passaggio dell’ago fino alla cute. L’iniezione 
pre-operatoria è stata ben tollerata in tutti i casi. Negli ultimi 5 anni abbiamo rioperato 13 pazienti con sospetta recidiva linfonodale nel 
compartimento centrale (tutte derivanti da carcinomi papillari) utilizzando la tecnica della marcatura con carbone vegetale. L’esame 
istologico definitivo e gli esami ecografici post-operatori hanno confermato la rimozione delle lesioni sospette in tutti i pazienti; in un caso 
la lesione è risultata essere una cisti paratiroidea. Abbiamo registrato complicanze chirurgiche in 2 casi (15,4%); in un caso si è trattato 
di ipoparatiroidismo e nell’altro di paresi della corda vocale, entrambi transitori. Considerando la nostra esperienza possiamo affermare 
che la marcatura pre-operatoria con carbone vegetale è una tecnica sicura, di costo irrisorio ed estremamente utile al chirurgo durante i 
reinterventi poiché, agevolandone le manovre, permette una riduzione dei rischi di danni iatrogeni. 
PArole ChiAve: Marcatura con carbone • Recidiva di carcinomi tiroidei differenziati • Comparto centrale • Complicanze chirurgiche
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Introduction
The incidence of recurrence of differentiated cancer af-
ter  thyroidectomy  has  increased  following  the  routine 
employment of ultrasound (uS) and thyroglobulin (Tg) 
determination. Among patients treated for differentiated 
thyroid cancer, persistent or recurrent disease occurs in 
5-40% of cases 1. Treatment with radioiodine alone can 
determine complete elimination of a recurrent tumour in 
many cases. nevertheless, up to 30% of tumours will not 
show 131i uptake, and these can be regarded to have a more 
aggressive behaviour with a poorer prognosis 2. F. Soprani et al.
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in these cases, surgical management of the lesions is re-
quired. Alternatively, as the impact of early detection and 
treatment on overall survival is highly debated, a second 
strategy, namely “wait and see”, is sometimes adopted; 
however, in the majority of cases, this such a policy is re-
fused by patients who prefer to orient themselves towards 
more radical therapy.
during reoperation, however, the risk of surgical compli-
cations is significantly higher 3. The surgeon may encoun-
ter problems in identification and preservation of recurrent 
laryngeal nerves and parathyroid glands due to fibrosis 
and scar tissue formation in the surgical field, with conse-
quent alteration of normal anatomic relationships.
Another aspect to be considered during reoperation is on-
cologic radicality, recurrent nerves and parathyroids may 
be infact encased in fibrotic tissues making them indistin-
guishable from pathologic tissue, with the risk of leaving 
residual neoplasm 4.
in order to circumvent these problems during reoperation 
in cases of differentiated thyroid cancer recurrence, in our 
centre during the last few years we have used a technique 
(adopted from breast diagnostics) that consists in preop-
erative  uS-guided  tattooing  (uS-tattoo)  localization  of 
the lymphatic structure to be removed.
To  our  knowledge  only  two  articles  have  reported  the 
technique of uS-tattoo localization by means of charcoal 
for cervical recurrence after thyroidectomy 2 3 . herein, we 
report our experience in terms of facilitating localization 
and surgical excision of lymphatic metastasis in level vi 
during reoperation for differentiated thyroid cancer. 
Materials and methods
This prospective study was conducted on 13 patients (10 
females and 3 males) with an average age of 42 years 
(range 25-70 years) who were referred to our centre (3 
were initially treated in another hospital) with a suspected 
recurrence of differentiated thyroid cancer in the central 
compartment. The initial operation and pTnm classifi-
cations are shown in Table i. Preoperative evaluation of 
vocal fold motility and parathyroid function was normal 
in all patients. radioiodine treatment was administered to 
12; it was not performed in 1 patient affected by microcar-
cinoma with no metastatic nodes found on prophylactic 
neck dissection (pT1n0).
recurrent or suspicious lesions were discovered during 
follow-up by uS and TSh-stimulated Tg determination; 
the nature of the suspicious lesions was then investigated 
by cytology (FnA) in association with Tg determination 
in the washout of fine needle aspiration (FnAB-Tg); in 
2 patients, laboratory tests were not useful for diagnosis, 
but on the basis of uS aspects surgical removal was per-
formed. The average time of recurrence was 18 months 
(range 3-48 months).
in all cases, recurrent lesions were located in the central 
compartment (level vi); in 5 cases, there was a concomi-
tant localization in other levels of the neck. in these pa-
tients, the nodes of lateral compartments were not marked 
because  based  on  pre-operative  examinations  selective 
neck dissection was performed (starting from level ii or 
iii to level iv or v). informed consent was obtained from 
all patients.
A suspension of active charcoal 40 mg/ml (4%) devel-
oped for tattooing breast cancer was used (80 mg active 
charcoal + 80 mg polysorbate-80 + water for injectable 
preparations to reach 2 ml).
under uS guidance the lesion is identified, and after the 
needle is carried just near the suspected lesion (we prefer 
to avoid injecting inside the lesion so as not to compromise 
histological examination) we proceeded with injection of 
0.5-2 ml of charcoal solution. The amount that must be 
injected depends on the depth of the lesion. in proximity 
of the suspected neoplasm a store of colouring, which we 
defined as a charcoal “puddle”, takes form (Fig. 1). 
The extraction of the needle is accompanied by injection 
at constant pressure of additional charcoal solution in or-
der to leave a trace of colouring along the path of the nee-
dle up to the skin, where a tattoo resembling a small nevus 
will persist for some weeks.
This last expedient provides, during surgical intervention, 
a valid indication regarding the direction to follow in or-
der to reach the suspected metastatic lesion (Fig.  2).
The procedure is executed from a few days to weeks be-
fore surgery, as it has been demonstrated that charcoal re-
mains in place for at least 3 months after injection 5 6.
Charcoal injection is performed in an outpatient clinic; 
after at least 20 min of observation the patient can return 
home. on the day of the procedure, the patient is advised 
to rest, avoiding bending the bust and head and raising 
heavy loads. in case of soreness or pain where the needle 
was inserted, the use of an analgesic is recommended.
Results
Preoperative injection was well tolerated in all cases; pa-
tients complained of the same slight discomfort of a FnA, 
experienced previously by all patients. no complications 
related to the procedure of uS-tattooing were observed.
in the last 5 years, we have reoperated 13 patients for sus-
pected metastatic lesion of differentiated thyroid cancer in 
level vi using uS-tattoo localization. 
immediately before surgery, we performed uS examination 
in the operating theatre to have a better conception of lesion 
localization (Fig. 3). Preoperative uS was especially help-
ful in defining the anatomical relationships of metastatic le-
sions, whereas for identification in a surgical field with dif-
fuse scar tissue the trace of charcoal was also highly useful.
Suspected lesions were removed successfully in all pa-
tients, even if in 1 case we had to perform a second reop-
eration to localize the metastasis.Charcoal tattoo localization for differentiated thyroid cancer recurrence in the central compartment of the neck
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in 5 cases, the first operation was total thyroidectomy, in 7 
cases thyroidectomy with dissection of level vi and in 1 case 
a selective neck dissection was also performed (Table i).
For patients 1-5, reoperation consisted in dissection of 
level vi (including the marked node) in 3 cases and as-
sociated selective neck dissection in 2 cases (Table i). 
in  the  group  of  patients  who  firstly  underwent  central 
compartment lymphadenectomy, we considered the use of 
the charcoal tattoo to be important in ensuring inclusion 
of metastatic nodes in the dissection.
in the other patients who had already undergone a central 
compartment dissection during the first operation, based 
on intraoperative findings we removed only the charcoal-
localized node, while in others also fatty or connective 
tissue (suspected of containing other lymphatic nodes) 
surrounding the targeted lesion.
in this latter group of 8 patients, the removal of metastases 
in level vi was associated with selective lateral neck dis-
section in 3 cases (# 9-11).
As previously mentioned, 1 case (# 11) required another 
reoperation to localize the metastatic lesion. This patient 
was a young woman with a metastasis at levels vi and 
v who therefore underwent selective lateral neck dissec-
tion (with metastasis in 2 of 14 nodes) and the removal 
of marked node in level vi. on this occasion, we found 
unusually widespread diffusion of charcoal in the surgi-
cal field; nevertheless, a node was identified and removed 
that histological examination revealed to be a benign lym-
phadenopathy. eight months later and after another un-
successful treatment with 131i, the patient was operated on 
again; during the second reoperation we found a similar 
amount of charcoal in the surgical field.
in this context, we found and removed a lymphatic struc-
ture that upon frozen sections was a metastatic node of 
papillary carcinoma; definitive histological examination 
confirmed diagnosis.
Following this experience, we have preferred to perform 
frozen sections during all reoperations.
with the exception of this case we found intraoperatively, 
following the trace created during the extraction of the 
needle, the charcoal injected localized close to the sus-
pected lesion.
Table. I. Patient and tumour characteristics.
Case Sex Age (yr) 1st Op Pat pTNM 131I Rec FNA and Tg wt 2nd Op Node found Complications





2 M 39 Tot Pap pT2Nx Yes 23 Yes Lev. VI Yes
3+/5 L. VI
No
3 F 70 Tot Pap pT2Nx Yes 28 Yes Lev. VI Yes
2+/8 L. VI
No




5 F 26 Tot Pap pT2Nx Yes 13 Yes Lev. VI Yes
1+/6 L. VI
No
6 F 25 Tot + VI Pap pT1N0 No 3 Yes (NS) Single node Yes (para-
thyroid cyst)
No
7 F 36 Tot + VI Pap pT4N1a Yes 18 Yes Single node Yes No












10 F 35 Tot + VI Pap pT3N1a Yes 14 Yes Single node, 
Lev. II, III, IV 
Yes No
11 F 42 Tot + VI Pap pT3N1a Yes 8 Yes Single node, 





12 M 65 Tot + VI Pap pT3N1a Yes 15 Yes (NS) Single node Yes No





Op, surgical operation; Pat, pathology; Pap, papillary carcinoma; Tot, total thyroidectomy, Neck dissection: II subdigastric, III supraomohyoid, IV supraclavicular, V posterior 
triangle, VI central compartment; 131I post operation treatment with radioiodine; Rec, time of recurrence (months); FNA fine needle aspiration biopsy; Tg washout, 
thyroglobulin determined in the rinse liquid of the syringe after FNA; NS, not significant.F. Soprani et al.
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histological examination confirmed the removal of a met-
astatic lesion in all cases with the exception of # 6 where 
the excised mass was a parathyroid with a benign cyst. 
After surgery, we observed no significant complications. 
one patient (7.6%) had temporary hypoparathyroidism 
(the pathologist found a parathyroid in the histological 
specimen), and another (7.6%) had temporary recurrent 
nerve paralysis.
As mentioned above, we observed 1 (7.6%) false positive 
case that required a second operation due to spillage of the 
charcoal. Follow-up with uS and Tg determination for at 
least 6 months confirmed the positive outcome of surgery.
Discussion
Thyroid differentiated carcinoma represents the most com-
mon endocrine tumour. Fortunately, its clinical course is 
favourable considering that for all subjects treated, in spite 
an increasing number of cases in recent years, the 10-year 
survival rate is 90%, and the incidence in all deaths for 
neoplastic diseases is only 0.5% 7.
lymphatic metastasis of differentiated thyroid cancer is 
commonly considered of negligible importance for prog-
nosis.  in  numerous  studies,  in  fact,  there  has  been  no 
worsening of the survival rate in the n+ patients regard-
ing those n0 (percentages of survival rates of 10 years up 
to 95% for the papillary carcinoma, and up to 70% for 
follicular carcinoma) are reported 8-12.
moreover, another author reports that, while 56% of pa-
tients with papillary carcinoma had a clinically apparent 
nodal metastasis at the time of initial presentation, only 
5% developed subsequent nodal metastasis 13.
nonetheless, greater attention is being placed on “dis-
ease-free survival” considering, in spite of high survival 
values, the non-negligible incidence of disease recurrence 
(15-35% even at 20 years), with a meaningful impact on 
the quality of the life (due to the need for surgical reopera-
tions and/or of elevated doses of radioiodine) 14 15.
Considering this aspect, there is contrasting data in the 
literature, and various opinions exist regarding the thera-
peutic approach in n0 cases. 
no scoring system (AgeS, AmeS, dAmeS, eorTC) at-
tributes significant importance to lymphatic metastases in 
terms of prognosis, and therefore no precise indications 
exist 16-19.
only the Tnm stage system attributes prognostic signifi-
cance to local recurrences, as classified in stage iii pa-
tients > 45 years old with a n1 stage neoplasm.
Advocates of elective dissection of the central compart-
ment  justify  their  position  by  adducing  a  better  loco-
regional  control  of  disease,  the  possibility  for  correct 
staging, variable radioactive iodine uptake of lymphatic 
metastases and greater morbidity in surgical recovery; the 
possibility of damage of recurrent laryngeal nerve can 
reach 20% (ranging from 0.7 to 4.5% during first opera-
Fig. 3. US performed just before surgery showing localization of the lymph 
node, its anatomical relationships, the “puddle” of charcoal and the path of 
the injection.
Fig. 1. Paratracheal lymph node marked with charcoal injected next to it.
Fig. 2. Traces of charcoal are identified since the superficial layers of the 
dissection providing the direction to follow in order to reach the suspected 
lesion.Charcoal tattoo localization for differentiated thyroid cancer recurrence in the central compartment of the neck
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tion), and the risk of hypoparathyroidism can reach 30% 
(8 to 13% in primary procedures) 20 21.
in our experience, notwithstanding the small number of 
patients, we observed transitory hypoparathyroidism in 
1 case (7.6%) and transitory vocal cord paresis another 
(7.6%).
Critics of systematic dissection of the central compart-
ment assert that iatrogenic injuries are greater, postopera-
tive metabolic therapy is an optimal therapeutic instrument 
and that only a minimal percentage of micrometastases 
can evolve into clinically-evident disease, which does not 
affect the survival rate 10 12 13 22. 
in n0 cases, our therapeutic approach, following the indi-
cations of many authors, consists of preoperative (by uS 
and when possible FnA) and intraoperative exploration of 
lymph nodes of the central compartment with dissection 
in case of clinical suspect 10 22.
in spite of many therapeutic opinions regarding n0 necks 
in differentiated thyroid cancer, reoperations in the cen-
tral compartment may be necessary. Also, when a level vi 
level dissection is performed during first operation, in fact, 
radicality is very difficult to obtain, especially considering 
nodes situated on the edge of the mediastinal space.
when reoperative central compartment dissection is re-
quired, the morbidity rate is quite high because the sur-
geon may encounter significant difficulties in the identifi-
cation and preservation of recurrent laryngeal nerves and 
parathyroid glands. 
To prevent recurrent nerve injuries, it is possible to make 
use  of  intraoperative  neurological  monitoring  and/or 
identification of each nerve low in the tracheo-esophageal 
groove distant from the thyroid bed with meticulous sur-
gical inferior to superior dissection 4.
revision surgery of the central compartment places the 
parathyroid  glands  at  increased  risk  of  devasculariza-
tion or inadvertent removal. The most important aspect 
to prevent devascularization is preservation of the inferior 
thyroid artery. To avoid removal of glands the specimen 
should be carefully examined for parathyroid tissue; if 
identified, a biopsy should be performed for histological 
confirmation by frozen sections with reimplantation in 
sternocleidomastoid muscle.
in  practice,  however,  fibrosis  and  multiple  pathologic 
lymph nodes in the dissected specimen can make identifi-
cation of parathyroid tissue difficult with the risk of inad-
vertently reimplanting the tumour 4.
in spite of all these procedures, reoperative central com-
partment  dissection  remains  difficult  even  when  per-
formed by experts. in this context, uS-tattoo localization 
represents an instrument of considerable utility.
Conclusions
Considering our experience, we can affirm that uS-tattoo 
localization of lymphatic metastasis of differentiated thy-
roid carcinoma is a safe, inexpensive and extremely useful 
technique in facilitating surgical procedures, particularly 
difficult in a reoperated neck, and reducing the risk of ia-
trogenic damage towards parathyroid glands and recur-
rent laryngeal nerves. 
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